Dale E. Williams
Analyst · Longbow Research
Thanks, Mark. I'll focus my commentary on the third quarter financial results. In total, third quarter net sales were $383 million, an increase of 30%. On a constant-currency basis, sales were up 26%. North American sales increased 30%, and international sales were up 28%. On a constant-currency basis, our international sales increased 15%, reflecting the positive response to investments in marketing and new products. By channel, in North American retail, net sales were $257 million, an increase of 30%. Internationally, retail sales were up 37% to $86 million. On a product basis, total mattress sales were up 28%, driven by an 18% increase in units. North American mattress sales increased 28% on a 19% increase in units. The increased average unit selling price reflects favorable price and mix, partially offset by increased floor model discounts. In the International segment, mattress sales increased 31%. On a constant-currency basis, international mattress sales were up 18%, and mattress units increased 16%. In total, pillows were up 12% driven by a 3% increase in units. North American pillow sales increased 5% on a unit growth of 2%. International pillow sales were up 21% on a 5% volume increase. On a constant-currency basis, international pillow sales increased by 9%. Sales of our other product category, which includes items that are normally sold along with the mattress, were up 42%, reflecting continued improvements on Ergo attach rates in the U.S. Gross margins for the quarter was 52.4%, up 140 basis points year-on-year, but down 50 basis points sequentially. I am disappointed the margin rate was not up more. However, the reasons behind this are mostly transitory. While the underlying trends in our margin continue to be strong, in the third quarter we made some strategic investments, which lowered our overall gross margin. These investments include an IT system upgrade at our European manufacturing facility, new product launches, and a program that provides an opportunity for sales associates to purchase their own TEMPUR sleep system. All of these are supportive of long-term growth plans and provide a foundation for future growth. At the same time, we are experiencing unprecedented levels of demand for our new product launches internationally. This demand, in combination with some productivity issues arising from the upgrade, resulted in unacceptably low levels of inventories in some international markets. So rather than risk extensive back orders and further impact to customer service, we began shipping products from the U.S. to Europe and incurred incremental shipping costs. Despite this support from the U.S. plants and a significant improvement in productivity by the end of the quarter, our international business ended the third quarter with a record backlog. So to ensure the best possible levels of customer service, we will continue shipping to Europe in the fourth quarter. Now let me give you a breakdown of the key drivers of our gross margin. On a year-over-year basis, gross margin improvement related to our ongoing productivity programs generating improved efficiencies in manufacturing and distribution, favorable mix and fixed cost leverage related to higher production volumes. Partially offsetting these benefits were higher commodity costs and floor model discounts related to new product introductions. On a sequential basis, the modest decline in gross margin resulted from the impact of productivity issues related to the Danish manufacturing facility, higher commodity costs, floor model discounts related to new product launches and the retail sales associate program. Partially offsetting these items were improvements related to our ongoing productivity programs and fixed cost leverage. Looking at operating expenses, we increased our advertising investment by 170 basis points, reflecting our commitment to ensure everyone knows they would sleep better on TEMPUR. On our sales growth, we do have 80 basis points of operating expense leverage despite our increased investment in brand awareness. Our operating margins expanded by 220 basis points to 25.2%. Interest expense was $3.3 million. Net income was $61.9 million, up from $44.2 million last year. EPS was $0.90, up from $0.62 last year. Now I'll turn to the balance sheet for a brief review. We generated $75 million of operating cash flow and have $103 million of cash on our balance sheet. The majority of our cash balance is in our international markets. Receivables were up reflecting higher sales, while our DSOs were down approximately 3 days from the third quarter of last year and flat sequentially. Inventory decreased 3 days sequentially, principally reflecting the completion of the initial distribution of the Contour line in the U.S. Our inventory days were down considerably more in the international markets, especially so for our new products. Turning to our share repurchase program. Through open market purchases, we bought 1.34 million shares during the quarter at a total cost of $80 million. During the first 3 quarters of 2011, we bought back 4.25 million shares for a total cost of $240 million. Our funded debt-to-EBITDA ratio decreased modestly to 1.36x, despite an increase in debt outstanding deployed to purchase stock. As we said before, our target leverage ratio is 1.5 to 2x versus our debt covenant of 3x. We continue to view the share repurchase program as an excellent means to return value to shareholders over the long term. So we are pleased to announce that our board has expanded our share repurchase authorization by $80 million. Reflecting the shares we purchased in the third quarter, we currently have $200 million available under this authorization. Now I'd like to address our updated guidance for the full year. With our new outlook, we are balancing strong results through the first 3 quarters of 2011, while continuing to acknowledge the macroeconomic environment remains unclear. Industry conditions are volatile, and retail customers report that traffic is variable. Therefore, we are projecting the end of the year in a manner reflecting this uncertainty. We currently expect net sales to range from $1,405,000,000 to $1,425,000,000, and we currently expect EPS to range from $3.12 to $3.17 per diluted share. Regarding our outlook for gross margins, in the fourth quarter we anticipate a modest increase on a sequential basis, as margins will remain challenged by incremental shipping costs related to rebuilding international inventories and a conservative commodity outlook. We expect interest expense for the full year to be $13 million. We anticipate the full year tax rate to be 33.5%. We are lowering our share count projection to 69.5 million shares for the full year, which includes the net benefit from our repurchase activity through the third quarter. However, it does not assume benefit from the potential for a further reduction in shares outstanding. As noted in our press release, our guidance and these expectations are based on information available at the time of the release and are subject to changing conditions, many of which are outside the companies control. This concludes our prepared remarks, and at this point, operator, we would like to open the call to questions.